Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

3rd Sep 2013 12:57

RNS Number : 1203N
United Drug PLC
03 September 2013
 



Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

This notification is for filing purposes only in accordance with Regulation 22 of the Transparency (Directive 2004/109/EC) Regulations 2007.

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached[ii]:  United Drug Plc

 

2. Reason for the notification (please tick the appropriate box or boxes):

[ü] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]: FIL Limited

4. Full name of shareholder(s) (if different from 3.)[iv]: see schedule

5. Date of the transaction and date on which the threshold is crossed or reached[v]: 30th August 2013

6. Date on which issuer notified: 2nd September 2013

7. Threshold(s) that is/are crossed or reached: 5%

8. Notified details:

 

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii]

Number of Shares[viii]

Number of Voting rights[ix]

Number of shares[x]

Number of voting rights[xi]

% of voting rights

Indirect

Direct[xii]

Indirect[xiii]

Direct

Indirect

IE0033024807

12,082,299

12,082,299

11,706,399

11,706,399

4.85

SUBTOTAL A (based on aggregate voting rights)

12,082,299

12,082,299

11,706,399

11,706,399

4.85

 

B) Financial Instruments

Resulting situation after the triggering transaction[xiv]

Type of financial instrument

Expiration Date[xv]

Exercise/Conversion Period/ Date[xvi]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

SUBTOTAL B (in relation to all expiration dates)

 

Total (A+B)

number of voting rights

% of voting rights

11,706,399

4.85%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xvii]:

 

Sum of Factored Shares Held

Custodian

Advisor

Total

BROWN BROS HARRIMN LTD LUX (C)

FFML-FIL FUND MANAGEMENT LIMITED

2,464,243

FIDELITY INT LT-FIL LIMITED

6,677

BROWN BROS HARRIMN LTD LUX (C) Total

2,470,920

BROWN BROTHERS HARRIMAN AND CO

FIJ-FIDELITY INVESTMENTS JAPAN LIMITED

143,200

BROWN BROTHERS HARRIMAN AND CO Total

143,200

JP MORGAN, BOURNEMOUTH (C)

FII-FIL INVESTMENTS INTERNATIONAL

2,402,129

FILUK-FIL INVESTMENT SERVICES (UK) LIMITED

5,652,150

JP MORGAN, BOURNEMOUTH (C) Total

8,054,279

MELLON BANK (S)(C)

FPM-FIL PENSION MANAGEMENT

175,100

MELLON BANK (S)(C) Total

175,100

NATIONAL ASTL BK MELBOURNE (S)

FIDELITY INT LT-FIL LIMITED

862,900

NATIONAL ASTL BK MELBOURNE (S) Total

862,900

Grand Total

11,706,399

 

 

 

 

10. In case of proxy voting: Number of voting rights proxy holder will cease to hold - 375,900

11. Additional information: None

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBBGDCUUGBGXX

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00